Symptoms & Disease Progression of AVED
At a Glance
AVED can progressively worsen balance, sensation, speech, and mobility without treatment, but consistent high-dose vitamin E often slows or stabilizes decline. Some coordination or speech may improve, although established nerve damage may remain.
Without treatment, Ataxia with Vitamin E Deficiency (AVED) is a progressive condition. Because the brain and nerves are deprived of essential antioxidant protection, damage accumulates over time, leading to worsening coordination and mobility [1][2]. However, the defining characteristic of AVED is its remarkable response to treatment: while established damage may persist, consistent high-dose vitamin E can significantly slow or stabilize the disease [3][4].
Primary Neurological Symptoms
The symptoms of AVED primarily reflect damage to the cerebellum (the brain’s coordination center) and the sensory nerves in the spinal cord [5].
- Gait Ataxia and Clumsiness: This is usually the first sign. It often begins as subtle unsteadiness or a tendency to trip and fall more often than others [6][2].
- Loss of Proprioception and Vibration: You may lose the ability to feel where your limbs are located without looking at them (proprioception) or feel the vibration of a tuning fork against your skin [1][7]. This makes walking in the dark or on uneven surfaces particularly difficult.
- Dysarthria: Damage to the nerves controlling speech can lead to slurred, slow, or “scanning” speech patterns [6].
- Areflexia: During a physical exam, a doctor may find that your deep-tendon reflexes (like the “knee-jerk”) are diminished or completely absent [1].
- Involuntary Movements: Some people experience head titubation (a rhythmic nodding or shaking of the head), tremors, or dystonia (involuntary muscle contractions that cause twisting movements) [6][8].
Extra-Neurological Symptoms
While the nervous system is the primary target, AVED can affect other parts of the body. These “extra-neurological” symptoms are important to monitor during regular check-ups.
- Skeletal Changes: Some patients with AVED develop scoliosis (a sideways curve of the spine) or foot deformities, such as high arches [6]. These are often secondary to the muscle weakness and nerve damage caused by the ataxia.
- Retinal Issues: A specific type of eye condition called retinopathy can occur. This may involve patchy areas of damage on the retina (the back of the eye) that can resemble retinitis pigmentosa [9][10].
- Cardiovascular and Systemic Health: While isolated reports in small families have noted premature hardening of the arteries (atherosclerosis) or heart disease, it is not an established defining feature of AVED for all patients [11]. Unlike Friedreich’s Ataxia, standard annual heart screenings are not universally required unless indicated by symptoms or family history.
The Overlap with Friedreich’s Ataxia (FRDA)
AVED is often called a “Friedreich’s Ataxia-like” syndrome because the two conditions look almost identical during a clinical exam [12]. Both involve progressive balance issues, speech changes, and a loss of reflexes [13].
The critical difference is the cause:
- FRDA is caused by a problem with the FXN gene and the protein frataxin [14]. It often involves significant heart complications (hypertrophic cardiomyopathy) and a higher risk of diabetes [15].
- AVED is caused by the TTPA gene and a vitamin E transport defect [1].
Because AVED is treatable and FRDA is managed differently, doctors must use specific genetic testing and vitamin E blood tests to tell them apart [12][16].
Disease Progression: With vs. Without Treatment
The speed at which AVED progresses varies. Symptoms typically start between ages 5 and 15, but some people are not diagnosed until adulthood [1][4].
| Feature | Without Treatment | With High-Dose Vitamin E |
|---|---|---|
| Gait/Walking | Progressively worsens; may lead to mobility aid use [6]. | Often stabilizes or slows progression [3]. |
| Nerve Damage | Continues to accumulate [2]. | Progression is significantly slowed [3]. |
| Symptom Reversal | None. | Some improvement in coordination/speech is possible, but established deficits may persist [4][6]. |
| Long-Term Outlook | Increasing disability over decades. | In one case report, a patient remained neurologically stable for over 30 years with adherence [3]. |
The takeaway for most families is one of cautious optimism: while vitamin E may not “undo” the damage that has already happened, it is an incredibly effective tool for protecting against future decline [3][2]. Consistent, lifelong treatment is the key to maintaining mobility and independence [17].
Common questions in this guide
What are the earliest signs of Ataxia with Vitamin E Deficiency?
How does AVED progress without treatment?
Can vitamin E treatment improve AVED symptoms?
How can doctors tell AVED apart from Friedreich's ataxia?
Can AVED affect the eyes, spine, or feet?
Are heart problems a common part of AVED?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my (or my child's) current symptoms, what is our baseline 'ataxia score' for monitoring treatment?
- 2.Have we ruled out Friedreich's Ataxia (FRDA) through specific genetic testing for the FXN gene?
- 3.Should we schedule a baseline screening with a neuro-ophthalmologist to check for retinal patches?
- 4.Are there signs of scoliosis or foot deformities that require physical therapy or orthotics right now?
- 5.What is the target vitamin E level for my specific case to ensure disease progression is halted?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (17)
- 1
Ataxia with vitamin e deficiency in norway.
Elkamil A, Johansen KK, Aasly J
Journal of movement disorders 2015; (8(1)):33-6 doi:10.14802/jmd.14030.
PMID: 25614784 - 2
Ataxia With Vitamin E Deficiency Syndrome and a Novel TTPA Variant: A Paired Case Report.
Baso G, Magri F, Sciacco M, et al.
Neurology. Genetics 2026; (12(3)):e200399 doi:10.1212/NXG.0000000000200399.
PMID: 42164107 - 3
First Recognized Patient with Genetic Vitamin E Deficiency Stable after 36 Years of Controlled Supplement Therapy.
Kohlschütter A, Finckh B, Nickel M, et al.
Neuro-degenerative diseases 2020; (20(1)):35-38 doi:10.1159/000508080.
PMID: 32623435 - 4
MNV-aware molecular characterization of a rare homozygous TTPA complex allele in ataxia with vitamin E deficiency.
Zaki-Dizaji M, Sarband MM
Molecular genetics and genomics : MGG 2026; (301(1)).
PMID: 42711446 - 5
The tocopherol transfer protein mediates vitamin E trafficking between cerebellar astrocytes and neurons.
Ulatowski L, Ghelfi M, West R, et al.
The Journal of biological chemistry 2022; (298(3)):101712 doi:10.1016/j.jbc.2022.101712.
PMID: 35150738 - 6
Analysis of clinical pedigree characteristics in Chinese patients with ataxia with vitamin E deficiency.
Lv P, Liu L, Hao Y, et al.
Molecular genetics and metabolism 2026; (148(4)):110167 doi:10.1016/j.ymgme.2026.110167.
PMID: 42259017 - 7
Ataxia due to vitamin E deficiency: A case report and updated review.
Thapa S, Shah S, Chand S, et al.
Clinical case reports 2022; (10(9)):e6303 doi:10.1002/ccr3.6303.
PMID: 36093469 - 8
Ataxia with Vitamin E Deficiency May Present with Cervical Dystonia.
Becker AE, Vargas W, Pearson TS
Tremor and other hyperkinetic movements (New York, N.Y.) 2016; (6()):374 doi:10.7916/D8B85820.
PMID: 27274910 - 9
Atypical retinopathy in ataxia with vitamin E deficiency: report of a sibship.
Abramowicz S, Dentel A, Chouraqui M, et al.
Neurogenetics 2024; (25(1)):33-38 doi:10.1007/s10048-023-00741-9.
PMID: 38105315 - 10
Syndromic retinitis pigmentosa.
Karuntu JS, Almushattat H, Nguyen XT, et al.
Progress in retinal and eye research 2025; (107()):101324 doi:10.1016/j.preteyeres.2024.101324.
PMID: 39733931 - 11
Familial vitamin E deficiency: Multiorgan complications support the adverse role of oxidative stress.
Trotta E, Bortolotti S, Fugazzotto G, et al.
Nutrition (Burbank, Los Angeles County, Calif.) 2019; (63-64()):57-60 doi:10.1016/j.nut.2018.11.012.
PMID: 30933726 - 12
A first description of ataxia with vitamin E deficiency associated with MT-TG gene mutation.
Maalej M, Kammoun F, Kharrat M, et al.
Acta neurologica Belgica 2021; (121(6)):1733-1740 doi:10.1007/s13760-020-01490-4.
PMID: 32979145 - 13
A Case of Ataxia with Isolated Vitamin E Deficiency Initially Diagnosed as Friedreich's Ataxia.
Bonello M, Ray P
Case reports in neurological medicine 2016; (2016()):8342653 doi:10.1155/2016/8342653.
PMID: 26989534 - 14
Assessing airway clearance dysfunction in Friedreich's ataxia: A focus on peak cough flow.
Smith BK, Coker MA, Liberati C, et al.
Journal of neuromuscular diseases 2026; 22143602261452334 doi:10.1177/22143602261452334.
PMID: 42253100 - 15
Characterizing cardiac phenotype in Friedreich's ataxia: The CARFA study.
Legrand L, Weinsaft JW, Pousset F, et al.
Archives of cardiovascular diseases 2022; (115(1)):17-28 doi:10.1016/j.acvd.2021.10.010.
PMID: 34920960 - 16
Friedreich's Ataxia: Clinical Presentation of a Compound Heterozygote Child with a Rare Nonsense Mutation and Comparison with Previously Published Cases.
Rao VK, DiDonato CJ, Larsen PD
Case reports in neurological medicine 2018; (2018()):8587203 doi:10.1155/2018/8587203.
PMID: 30159187 - 17
Ataxia with vitamin E deficiency in the Philippines : A case report of two siblings.
Tabuena MD, Morigaki R, Miyamoto R, et al.
The journal of medical investigation : JMI 2021; (68(3.4)):400-403 doi:10.2152/jmi.68.400.
PMID: 34759169
This page is for informational purposes only and does not constitute medical advice. A neurologist and your care team should interpret AVED symptoms, vitamin E levels, and genetic tests for your specific situation.
Get notified when new evidence is published on Ataxia with vitamin E deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.